Robert Stratta to Azathioprine
This is a "connection" page, showing publications Robert Stratta has written about Azathioprine.
Connection Strength
0.892
-
Kaczmorski S, Doares W, Winfrey S, Al-Geizawi S, Farney A, Rogers J, Stratta R. Gout and transplantation: new treatment option-same old drug interaction. Transplantation. 2011 Aug 15; 92(3):e13-4.
Score: 0.391
-
Stratta RJ. Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1353-4.
Score: 0.157
-
Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol. Transplant Proc. 1989 Feb; 21(1 Pt 2):1726-8.
Score: 0.082
-
Stratta RJ, Burlingham WJ, Pirsch JD, Armbrust MJ, Grailer A, Kalayoglu M, Belzer FO, Sollinger HW. Risk factors for rejection in a donor-specific transfusion plus azathioprine protocol. Transplant Proc. 1988 Dec; 20(6):1092-5.
Score: 0.081
-
Stratta RJ. Late acute rejection episodes after vascularized pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1560-1.
Score: 0.039
-
Stratta RJ, Sollinger HW, D'Alessandro AM, Pirsch JD, Kalayoglu M, Belzer FO. OKT3 rescue therapy in pancreas-allograft rejection. Diabetes. 1989 Jan; 38 Suppl 1:74-8.
Score: 0.020
-
Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy. Transplantation. 1989 Jan; 47(1):96-102.
Score: 0.020
-
Burlingham WJ, Stratta RJ, Mason B, Ambrust MJ, Kalayoglu M, Belzer FO, Sollinger HW. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol. Transplantation. 1988 Feb; 45(2):342-5.
Score: 0.019
-
Stratta RJ, Armbrust MJ, Oh CS, Pirsch JD, Kalayoglu M, Sollinger HW, Belzer FO. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation. 1988 Feb; 45(2):323-8.
Score: 0.019
-
Kalayoglu M, Stratta RJ, Hoffmann RM, Sollinger HW, Belzer FO. Quadruple immunosuppressive therapy for liver transplantation. Transplant Proc. 1988 Feb; 20(1 Suppl 1):524-9.
Score: 0.019
-
Chinnakotla S, Taylor RJ, DeRoover A, Stratta RJ, Leone JP. Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1696-7.
Score: 0.012
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):635-7.
Score: 0.007
-
Burlingham WJ, Stratta R, Mason B, Lorentzen D, Feyzi J, Sollinger HW, Belzer FO. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience. Transplantation. 1989 Jan; 47(1):140-4.
Score: 0.005
-
Pirsch JD, Sollinger HW, Kalayoglu M, Stratta RJ, D'Alessandro AM, Armbrust MJ, Belzer FO. Living-unrelated renal transplantation: results in 40 patients. Am J Kidney Dis. 1988 Dec; 12(6):499-503.
Score: 0.005
-
Oh CS, Sollinger HW, Stratta RJ, Kalayoglu M, Belzer FO. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin. Transplantation. 1988 Jan; 45(1):65-7.
Score: 0.005
-
Oh CS, Stratta RJ, Fox BC, Sollinger HW, Belzer FO, Maki DG. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation. 1988 Jan; 45(1):68-73.
Score: 0.005
-
Sollinger HW, Stratta RJ, Kalayoglu M, Pirsch JD, Belzer FO. Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression. Surgery. 1987 Oct; 102(4):674-9.
Score: 0.005